VMP 42296811000001101

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Nefopam 30mg tablets
BNF code 0407010P0AAABAB
Virtual Therapeutic Moiety Nefopam
Date identifier became valid 29 Sep 2023
Previous product identifier 322303005
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Nefopam hydrochloride
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 30.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Nefopam 30mg tablets (A A H Pharmaceuticals Ltd)
Nefopam 30mg tablets (Accord-UK Ltd)
Nefopam 30mg tablets (Alliance Healthcare (Distribution) Ltd)
Nefopam 30mg tablets (Brown & Burk UK Ltd)
Nefopam 30mg tablets (Glenmark Pharmaceuticals Europe Ltd)
Nefopam 30mg tablets (Key Pharmaceuticals Ltd)
Nefopam 30mg tablets (Medihealth (Northern) Ltd)
Nefopam 30mg tablets (Medreich Plc)
Nefopam 30mg tablets (Ria Generics Ltd)
Nefopam 30mg tablets (Rivopharm (UK) Ltd)
Nefopam 30mg tablets (Teva UK Ltd)
Nefopam 30mg tablets (Tillomed Laboratories Ltd)
Virtual Medicinal Product Packs
Nefopam 30mg tablets 30 tablet
Nefopam 30mg tablets 90 tablet

dm+d data retrieved from TRUD: release NHSBSA_4.4.0_20240429000001, imported on 29th April 2024 at 05:07:25.

Feedback